US C-arms' market size was valued at USD 1.1 billion in 2022. The US C-arms market industry is projected to grow from USD 1.2155 Billion in 2023 to USD 2.7 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 10.50% during the forecast period (2023 - 2032). The rising demand for C-arms and the Rise in cancer cases are the main market drivers anticipated to propel the US C-arms market in the United States.
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
The US C-arms market is witnessing a significant trend in technological advancements in imaging. There is a notable shift towards integrating advanced imaging technologies such as flat-panel detectors, 3D imaging capabilities, and improved image resolution. This allows for enhanced visualization during surgical and interventional procedures. The demand for real-time, high-quality imaging in orthopaedics, cardiology, and minimally invasive surgeries drives manufacturers to develop C-arms with cutting-edge imaging features. Integrating artificial intelligence (A.I.) for image processing and analysis further augments C-arms' diagnostic capabilities, providing healthcare professionals with valuable insights for more accurate and efficient procedures. This factor drives the market CAGR.
Furthermore, another prominent trend in the US C-arms market is the growing emphasis on mobile C-arms. These portable imaging systems offer flexibility and manoeuvrability, allowing healthcare providers to bring advanced imaging capabilities directly to the patient's bedside or in various clinical settings. The versatility of mobile C-arms is particularly valuable in emergencies, operating rooms, and intensive care units.
The convenience of on-the-go imaging and advancements in image quality and dose management position mobile C-arms as a preferred choice for healthcare facilities aiming to improve workflow efficiency and patient care. The market is witnessing a surge in demand for these mobile solutions, reflecting a broader trend towards decentralized and patient-centred imaging practices in the U.S. healthcare landscape. Thus driving the US C-arms market revenue.
The US C-arms market segmentation, based on product, includes Fixed C-arms and Mobile C-arms. Mobile C-arms emerge as the dominant category in the US C-arms market, driven by their enhanced flexibility and the ability to provide point-of-care imaging solutions. These portable systems are designed for easy manoeuvrability, allowing healthcare providers to bring advanced imaging capabilities directly to various clinical settings, including operating rooms, emergency departments, and intensive care units.
Additionally, fixed C-arms are experiencing rapid growth, driven by ongoing technological advancements and their applicability in specialized procedures. Fixed C-arms, typically installed in dedicated imaging rooms, offer higher imaging capabilities and are often preferred for complex surgeries and interventional procedures. Integrating advanced imaging technologies, such as 3D capabilities and improved image resolution, positions fixed C-arms as crucial cardiology, orthopaedics, and neurosurgery tools.
Figure1: U.S. C-arms Market, by Product, 2022 &2032 (USD Billion)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
The US C-arms market segmentation, based on Application, includes Orthopaedics and Trauma, Neurosurgery, Cardiovascular, Pain Management, Gastroenterology, and others. Orthopaedics and Trauma emerge as the dominant category in the US C-arms market, primarily driven by the proliferation of minimally invasive orthopaedic procedures. C-arms are crucial in real-time imaging during orthopaedic surgeries, such as joint replacements, fracture fixations, and spinal interventions.
The ability to visualize anatomical structures with precision aids surgeons in achieving optimal placement of implants and ensures accurate alignment. Additionally, the fastest-growing segment in the US C-arms market is Cardiovascular applications, propelled by advancements in interventional cardiology. The integration of C-arms in cardiovascular procedures, such as angiography and cardiac interventions, is experiencing notable growth due to the increasing prevalence of cardiovascular diseases and the expanding array of minimally invasive cardiac procedures.
In the United States, the C-arms market is characterized by a dynamic landscape driven by technological advancements and specialized medical applications. Mobile C-arms, offering enhanced flexibility and point-of-care imaging, dominate the market, aligning with the trend towards decentralized healthcare. The orthopaedics and trauma application holds dominance, fueled by the increasing adoption of minimally invasive orthopaedic procedures. Simultaneously, cardiovascular applications are experiencing rapid growth, propelled by advancements in interventional cardiology and a rising prevalence of cardiovascular diseases. The US C-arms market reflects a commitment to advancing medical imaging technologies, catering to diverse medical specialities and contributing to improved patient outcomes in orthopaedics, Trauma, cardiology, and beyond.
The top companies in the US C-arms
Market are making significant investments in research and development to broaden their product offerings, driving further growth in the industry. These market leaders are also engaging in strategic initiatives such as introducing new products, forming partnerships, and pursuing mergers and acquisitions to expand their presence. In order to thrive in an increasingly competitive market, the US C-arms sector must provide cost-efficient products.
Major players in the US C-arms market are attempting to increase market demand by investing in research and development operations, including Abbott. (U.S.), Assing S.p.A (Italy), BMI Biomedical International s.r.l. (Italy), AADCO Medical, Inc. (U.S.), Eurocolumbuss.r.l. (Italy), Shimadzu Corporation (Japan), ITALRAY (Italy), Hologic, Inc. (U.S.), Villa SistemiMedicali Spa. (Italy).
US C-arms Industry Developments
July 2022:Siemens Healthineers received approval from the Food and Drug Administration (FDA) for the ARTIS iconic ceiling, a ceiling-mounted c-arm angiography system designed for various routine and advanced procedures in interventional radiology (I.R.) and cardiology.
January 2022:With its Zenition line of mobile c-arm systems, Philips has combined cloud-based artificial intelligence (A.I.) and 3D mapping to improve endovascular treatment outcomes and workflow efficiency.
| Report Attribute/Metric | Details |
| Market Size2022 | USD 1.1 Billion |
| Market Size 2023 | USD 1.21 Billion |
| Market Size2032 | USD 2.70 Billion |
| Compound Annual Growth Rate (CAGR) | 10.50% (2023-2032) |
| Base Year | 2022 |
| Market Forecast Period | 2023-2032 |
| Historical Data | 2018- 2022 |
| Market Forecast Units | Value (USD Billion) |
| Report Coverage | Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | Product, Application, and Region |
| Countries Covered | The U.S. |
| Key Companies Profiled | Abbott. (U.S.), Assing S.p.A (Italy), BMI Biomedical International s.r.l. (Italy), AADCO Medical, Inc. (U.S.), Eurocolumbuss.r.l. (Italy), Shimadzu Corporation (Japan), ITALRAY (Italy), Hologic, Inc. (U.S.), Villa SistemiMedicali Spa. (Italy) |
| Key Market Opportunities | Rising trend of new product approvals |
| Key Market Dynamics | Rising demand for C-arms Rise in cases of cancer |
US C arms Market Highlights:
Frequently Asked Questions (FAQ) :
The U.S. C-arms market size was valued at USD 1.1Billion in 2022.
The market is projected to grow at a CAGR of 10.50% during the forecast period, 2023-2032.
The key players in the market areAbbott. (U.S.), Assing S.p.A (Italy), BMI Biomedical International s.r.l. (Italy), AADCO Medical, Inc. (U.S.), Eurocolumbuss.r.l. (Italy), Shimadzu Corporation (Japan), ITALRAY (Italy), Hologic, Inc. (U.S.), Villa SistemiMedicali Spa. (Italy).
The Mobile C-Arms category dominated the market in 2022.
Orthopaedics and Trauma had the largest share of the market.
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
